Metastatic sites and lesion numbers cooperated to predict efficacy of PD‐1 inhibitor‐based combination therapy for patients with metastatic colorectal cancer

Metastatic sites and lesion numbers cooperated to predict efficacy of PD‐1 inhibitor‐based combination therapy for patients with metastatic colorectal cancer

Abstract Background Limited data have been used to evaluate the efficacy of immunotherapy in metastatic colorectal cancer (mCRC). Furthermore, potential markers that can be used to identify responding patients and to further improve efficacy have not been fully explored. Methods and Results In our s...

Full description

Bibliographic Details
Main Authors: Weiqin Jiang, Yinjun He, Wenguang He, Xiang Zhang, Nan Chen, Yandong Li, Weixiang Zhong, Guosheng Wu, Xile Zhou, Hanju Hua, Feng Ye
Format: Article
Language:English
Published: Wiley 2023-06-01
Series:Cancer Medicine
Subjects:
colorectal cancer
combination immunotherapy
liver metastasis
PD‐L1
predictive markers
Online Access:https://doi.org/10.1002/cam4.5959

Internet

https://doi.org/10.1002/cam4.5959

Similar Items